Patents

US 12624003 B2: Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases

Granted
2026-05-12
Filed
2021-12-22 application 18267551
Type
Utility · 19 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.

Source: PTBLXML, file of 2026-05-12 (ipgb20260512.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Celgene Corporation 413 patentsUS company or organizationPrinceton, NJPTBLXML, file of 2026-05-12

Inventors

InventorPlacePatentsPerson pageSource
Jeffrey M. SchkeryantzSummit, NJPTBLXML, file of 2026-05-12
Julie SelkirkSummit, NJPTBLXML, file of 2026-05-12
Philip Stewart TurnbullSan Diego, CAPTBLXML, file of 2026-05-12
Junko TamiyaCarlsbad, CAPTBLXML, file of 2026-05-12
Patrick W. PapaCarlsbad, CAPTBLXML, file of 2026-05-12
Jean-Francois BrazeauSan Diego, CAPTBLXML, file of 2026-05-12
Karin WormSummit, NJ5PTBLXML, file of 2026-05-12

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D205/12PTBLXML, file of 2026-05-12
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/28PTBLXML, file of 2026-05-12

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.